A 6-Week Open Label Cross-Over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) (PALAT)
This study has been completed.
Study NCT00209261
Information provided by Ferring Pharmaceuticals
First Received: September 13, 2005
Last Updated: February 19, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
